While we could not distinguish between Th1 and Th2 CD4+ T cells in our data, polymeric nanoparticles have previously been reported to induce Th1 phenotypes, motivating further study on how cargo-free nanoparticles stimulate anti-cancer adaptive immune responses (55, 56). The gene discussed is CD4; the disease is cancer.